

Squawk on the Street
CNBC
CNBC’s “Squawk on the Street” with Carl Quintanilla, Jim Cramer and David Faber is broadcast from the floor of the New York Stock Exchange, on site at the opening bell with the up-to-the-minute news investors need to know and interviews with the most influential Chief Executive Officers and greatest market minds.
Episodes
Mentioned books

6 snips
May 22, 2025 • 43min
House Passes Trump's Tax Bill, Long Bond Yield Jumps, Tesla Gets Leapfrogged 5/22/25
Markets reacted strongly to the House passing a significant tax bill, pushing the 30-year bond yield above 5.1%. Tesla faced new competition as BYD outsold it in Europe for the first time. Bitcoin hit a fresh all-time high, attracting younger investors despite economic uncertainties. OpenAI's acquisition of a startup from ex-Apple designer Jony Ive sparked discussions about innovation. Amid the financial landscape, reactions to retail earnings from brands like Ralph Lauren added another layer to the market's complexity.

7 snips
May 21, 2025 • 43min
SOTS 2nd Hour: Musk’s Vision For Tesla, DC Deal Or No Deal, and Time To Break-up Google? 5/21/25
Elon Musk, CEO of Tesla and known for his groundbreaking work in electric vehicles and space exploration, discusses his ambitious vision for self-driving cars and the future of Tesla's robotaxis. He navigates the competitive landscape, especially against Chinese manufacturers like BYD. The podcast also examines the potential breakup of Alphabet to enhance shareholder value, alongside insights into rising market pressures and economic shifts impacting companies like Target and United Health. Musk’s thoughts on AI and tech innovation provide compelling food for thought.

5 snips
May 21, 2025 • 43min
Tax Bill Standoff Effect, Musk Highlights, Target Off the Mark 5/21/25
Politics and markets collide as a tax bill standoff sends stocks tumbling. Catch insights from a blockbuster interview with Elon Musk, who shares bold visions for robotaxis and AI. Retailers like Target face tough challenges amid disappointing earnings, prompting discussions on pricing strategies against competitors. UnitedHealth contends with a Medicare fraud probe, raising questions about healthcare regulations. The complexities of legislation are examined, alongside the impact of rising yields on the economy.

10 snips
May 21, 2025 • 43min
CNBC Special: Tesla CEO Elon Musk 5/20/25
In this engaging talk, Elon Musk, the visionary CEO of Tesla and X, shares insights on electric vehicles and artificial intelligence. He discusses the eagerly anticipated launch of Tesla's robo-taxi service, emphasizing strides toward full autonomy. Musk addresses the challenges of self-driving tech, balancing safety with innovation, especially in competitive markets like China. He also delves into the future of AI, advocating for both optimism and caution, while highlighting the massive infrastructure needs for advancing autonomous systems and the responsibilities that come with it.

May 20, 2025 • 43min
SOTS 2nd Hour: Trump On The Hill, Google’s Existential Moment, and Home Depot’s Different Take On Tariffs 5/20/25
Jack Hittery, author and CEO of Sandbox AQ, shares insights on the competitive dynamics of AI and quantum computing. He discusses the rising stock prices and the potential impact of Google's upcoming announcements. The conversation touches on the implications of quantum tech for Bitcoin security and the geopolitical landscape between the U.S. and China. Hittery also highlights the urgent legislative moves by Trump to unite Republicans on crucial tax bills as the market faces fiscal pressures and innovative shifts within the tech sector.

May 20, 2025 • 46min
Trump on Capitol Hill, Home Depot's Tariff Message, Musk Countdown 5/20/25
Donald Trump, the 45th President of the United States, discusses his strategic push for tax cuts on Capitol Hill, aiming to unite House Republicans. He shares insights on his administration's economic successes while critiquing opposing policies. The conversation also dives into Home Depot's financial performance and its pricing strategies amid tariffs. Additionally, market trends are examined, including anticipation for Elon Musk's upcoming interview, with implications for both Tesla and the broader retail sector.

May 19, 2025 • 4min
Cramer's Morning Take: Capital One 5/19/25
Hear why Capital One is making waves in the financial sector with its strategic acquisition of Discover Financial Services. The hosts discuss how this move positions Capital One as a formidable competitor to giants like MasterCard and Visa. They delve into the company's operational strengths and its potential for share buybacks. In a twist, they also touch on Apple's challenges in the AI arena, highlighting how cultural factors and timing may impact its market dominance.

10 snips
May 19, 2025 • 42min
SOTS 2nd Hour: Moody’s Downgrade Hits Stocks, “Jensanity”, and Trump Tax Bill Hang-ups 5/19/25
Tom Lee, Head of Research at Fundstrat Global Advisors, shares his optimistic take on U.S. equities despite Moody’s recent credit downgrade. Rick Santelli, CNBC’s on-air editor, delves into the implications for market dynamics and consumer confidence. They discuss Walmart’s responses to tariffs and the tension with government policy. Additionally, the spotlight shines on Nvidia’s AI advancements and the historic listing of Coinbase in the S&P 500. The conversation wraps up with updates on Trump’s tax bill and the state of political and economic challenges.

May 19, 2025 • 41min
Moody’s Downgrades U.S., “Eat the Tariffs,” Nvidia CEO’s AI Keynote 5/19/25
Rick Santelli, an on-air editor for CNBC, and Tom Lee, Head of Research at Fundstrat Global Advisors, delve into Moody's downgrade of the U.S. credit rating, igniting discussion on market reactions and the 30-year yield spike. They dissect President Trump's remark about Walmart "eating the tariffs" and explore the implications for retailers. The conversation also covers Nvidia's latest AI innovations, highlighting the strategic partnerships shaping tech's future, and insights into JP Morgan's Investor Day and the financial landscape.

May 16, 2025 • 3min
Cramer's Morning Take: Eli Lilly 5/16/25
The discussion dives into the competitive dynamics of the pharmaceutical industry, showcasing why Eli Lilly's injectables outperform rivals like Wagovi and Ozempic. Insight is provided on Eli Lilly's recent stock performance and strategic advantages in comparison to Novo Nordisk. A leadership change at Novo Nordisk adds intrigue to the market positioning of these companies. Overall, it paints a picture of evolving consumer medication choices and the challenges major pharmaceutical players face.